viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Omeprazole sodium
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Antra
Itaalia, Saksamaa, Sveits
Biomezol
Ecuador
Cezole
Maroko
Ciplaprazole
Kolumbia
Dinsadrix
Mehhiko
Fendiprazole
Argentiina
Finulcer
Mehhiko
Fordex
Venetsueela
Gaspiren
Brasiilia
Gastromax
Venetsueela
Gerdex
Mehhiko
Haitrax
Mehhiko
Helicid
Poola
Imaroz
Tšiili
Inhibitron
Mehhiko
Ipproton
Saudi Araabia, Tuneesia
Klomeprax
Argentiina, Ecuador
Lordin
Kreeka
Losec
Austria, Belgia, Holland, Itaalia, Poola, Saudi Araabia, Suurbritannia, Türgi
Mepral
Itaalia
Omeprazen
Itaalia
Omeprazol
Saksamaa
Omeprazole
Prantsusmaa
Oprazole
Saudi Araabia
Penrazol
Kreeka
Rizek
Saudi Araabia
Timezol
Argentiina
Ulcozol
Argentiina
Ultop
Horvaatia
Viited : Omeprazole sodium
tüüp
avaldamine
186
ajaleht
Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264
ajaleht
Leboucher G, Charpiat B.
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Pharm Hosp Fr 1997 ; 121: 124.
1703
ajaleht
Schuster F, Bernard R.
Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln.
Krankenhauspharmazie 1995 ; 16: 101-103.
2231
ajaleht
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311
ajaleht
Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
J Clin Pharm Ther 2009 ; 34: 25-31.
3332
Labor
Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3658
Labor
Omeprazole - Summary of Product Characteristics.
Sandoz 2014
3823
ajaleht
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3871
plakat
Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M.
Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ?
Synprefh Congress Clermont Ferrand, France 2016
3976
ajaleht
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985
plakat
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Hopipharm Congress 2017 - Nancy 2017
4316
ajaleht
Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F.
Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion.
J Pharm Technol 2006 ;22:95-98.
4642
plakat
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
SEFH Congress (Virtual) October 2021 2021
Mentions Légales